Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy
Clinical trial NCT05222971 · RECRUITING
Trial details
- NCT number
- NCT05222971
- Sponsor
- Asan Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2025-12-30
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.